Searchable abstracts of presentations at key conferences in endocrinology

ea0063p341 | Thyroid 1 | ECE2019

Hashimotos encephalopathy in Graves’ disease

Al Salam Randa Abd , El Hadad Hemmet , Radwan Mona , El Meligy Amr , Galal Mai , Salam Randa

Introduction: Hashimoto’s encephalopathy is a neurological disorder of unknown cause associated with thyroid autoimmunity. It is easy to misdiagnose or overlook and the symptoms frequently lead to mistaken neurological diagnoses. The disease may present in two types – a sudden vasculitic type or a progressive subacute type associated to cognitive dysfunction, confusion and memory loss.Case report: A 34 year old male presented to our emergency d...

ea0070aep394 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Thiamine-responsive megaloblastic anemia syndrome with dysrhythmia

El Ebrashy Ibrahim , El Haddad Hemmat , Moustafa Heba , Galal Mai , Salam Randa , Magdi Mohamed

Introduction: Thiamine responsive megaloblastic anemia syndrome(TRMA), is an autosomal recessive disorder due to mutation of gene (SLC19A2) encoding thiamine transporter protein TRMA ischaracterized by a triad of anemia, diabetes mellitus, and sensorineural deafness.Case report: A 15 year old girl admitted to the ERwith diabetic ketoacidosis. She was diagnosed as neonatal diabetesat the age of 16 months and wasput on insulin therapy. Her parents arehealt...

ea0081ep872 | Reproductive and Developmental Endocrinology | ECE2022

Assessment of early vascular changes in adult females with polycystic ovary syndrome in correlation with insulin resistance

Fathy Marwa , Mansour Mona , Saif Aasem , Elhamid Alaa Mahmoud Abd , Mohamed Adel , Galal Mai , Moussa Shrouk , Saad Samar

Background: Polycystic ovary syndrome is a long lasting, complex, hormonal condition associated with microvascular endothelial dysfunction and strongly related to CIMT changes at an early age. ED represents an initial reversible step in atherogenesis development, so early clinical identification of ED may play a pivotal in the prevention or reversal of progression to atherosclerosis. Also, CIMT is considered as an early marker of atherosclerosisObjective...